Successful proof of concept with imsus platform technology: Preclinical development of a 1-month controlled release formulation for a peptide drug
| Autor: | Albayrak, C., Seemann, H., Rindler, V., Brochard, A., Mondoly, N. |
|---|---|
| Zdroj: | In Journal of Controlled Release 2008 132(3):e77-e79 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect